chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe, full-body muscle pain beginning the morning following my second vaccination. This was tempered only a little with 600mg of ibuprofen, but the aches worsened around 3pm, a full 24 hours after my shot. On Saturday morning I was unable to leave the bed due to how painful it was to move. My legs hurt the worst, I couldn't lift, bend, or walk on my legs in the morning. I also had severe pain in my lower back, my hands, wrists, and forearms. I forced myself to walk through tears and agony which eventually helped "loosen" my legs. Throughout the day the mobility in my legs came back and the pain eased slightly. I continued to need to either support myself or rest often.  On Sunday the same symptoms as described above came back with a vengeance. I didn't have to even move to be in agony all of the time. Forcing myself to break through the stiffness and pain seemed to help awaken and revive my muscles slightly. Ibuprofen didn't help much, I was taking a maximum of 800mg doses about three times a day.  Monday is the first day the pain is not unbearable, though it is extremely painful and difficult to move. I struggle to go up or down stairs, I struggle to get up from a sitting position, I struggle to put my pants on, and I struggle to walk. If I stand for too long of a duration my legs shake and I feel like I might collapse.
lympadenitis & cellulitis-rt axilla tx w/ATB;seen by MD;
Itching at the injection site; Pain at the injection site; Redness at the injection site; Swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 06L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site) had resolved.    No treatment information was provided.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pharmacy intern reconstituted the pediatric Pfizer vial instead of the adult Pfizer with 1.8ml saline and administered 0.3 ml to patient. Patient may have received a too-diluted dose that may not illicit an appropriate immune response
59-year-old female brought in by EMS for shortness of breath and chest pain 2/17 and tests positive for COVID upon admission, heparin infusing as ordered. Pt is on Incruse and albuterol 2/18. Patient is AOx4, vss, ivs are patent, patient gets up to bedside commode with assist, urinating well, heparin discontinued, lovenox ordered 2/18. Pt remained AO x 4 with moments of forgetfulness, maintained O2 saturation in 90s at room air 2/21. Pt stable for discharge home with no needs on 2/21.
Pt recvd 1st dose of HIB/DTP/OPV on 26SEP91 & following inject pt exp bilateral redness of both legs, also blanching @ inject sites; pt tx w/APAP & DPH; pt recovered; Pt recvd 2nd dose HIB w/no rxn noted;
First night (11/15/18) had chills, pounding heart on the left side of my rib cage, and my face seemed swollen. Next day (11/16/18) had chills on scalp and upper body. Then midday, I had stomach pain, had a swollen red face, leg weakness, body aches, nausea, headache, and neck hurt. Then that night my eyes started burning, my heartbeat was fast, and while I slept I sweat profusely. On 11/7/18, I still had a headache and neck pain, but the other symptoms were gone. Now the night of 11/17/18 and I no longer have symptoms.
early pregnancy after receiving the second dose of the moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (early pregnancy after receiving the second dose of the moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (early pregnancy after receiving the second dose of the moderna vaccine). At the time of the report, EXPOSURE DURING PREGNANCY (early pregnancy after receiving the second dose of the moderna vaccine) outcome was unknown.            Concomitant product use was not provided by the reporter   Treatment information was not provided.    Reporter did not allow further contact
high pitched;screaming episode w/no more than 15min sleep & then awakened screaming from 4Pm to 1130PM on 10/17 & Saturday until 11AM 10/18;
On the day after the vaccine, 4/8/21 I woke up and felt heaviness in both legs as I walked around my home.That lasted for 2 days. on Saturday 4/10/21 those symptoms diminished slightly and I felt sleepy all day long. On Sunday 4/11/21 I woke up with numbness and heaviness  on the entire left half of my body and was unable to walk properly.  That evening I went to the Emergency Department. After review of CT and MR, I was diagnosed with having a stroke. I remained there for about 18 hours . My symptions decreased to tingling , so Iwas discharged, no treatment received. As of today, my sympttions are reduced almost amost 50% and i am able to walk with a walker..
Developed severe (>100 lesions) case of varicella 11/15/02.
developed a rash on different areas of her body; now changed into hives/blisters (on her chin, back and arms); Initial information regarding an unsolicited valid non-serious case received via patient on 21-Oct-2022.  This case involves an 84-year-old female patient who experienced developed a rash on different areas of her body and now changed into hives/blisters (on her chin, back and arms) while receiving vaccine Influenza Quadrival A-B HIGH DOSE HV Vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 03-Oct-2022, the patient received suspect Fluzone High-Dose Quadrivalent vaccine at dose 0.7 ml total at (unknown: formulation, strength, lot number, route in unknown administration site) for influenza vaccination.  On 03-OCT-2022, the patient developed a non-serious developed a rash on different areas of her body (rash) and now changed into hives/blisters (on her chin, back and arms) (urticaria) following the administration of Fluzone High-Dose Quadrivalent vaccine.  Action taken: Not applicable.  Corrective treatment: The patient was treated with Triamcinolone Acetonide for Rash and Urticaria.  At time of reporting, the outcome was Not Recovered for both events.
Shingles; Inappropriate schedule of vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, 91 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that he had a friend who received the first dose of Shingrix a little over 6 months or so, and developed a case of shingles about 3 months after receiving the dose. The patient was fully recovered and also did not have any post-herpetic neuralgia.  Till the time of report the patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter was inquiring if she should receive the 2nd dose.
w/in 2 days p/vax pt devel area of erythema 5cm x 3cm around site of inj;very warm to touch;had inc in size, doubling each day;
Patient has been experiencing repeated redness, swelling, and itching at the injection site. The skin is also slightly warm. The rash is about 2.5 X 2.5 inches. The rash will resolve without treatment. The rash will last from a few hours to all day. The rash develops off and on unpredictably from a few time a week to once in a few months. He has not had any other reactions with Anthrax immunizations. This is his 4th Anthrax vaccine injection. He has full and normal use of his arm when the rash develops.
scratchy, slightly itchy sensation at the back of my mouth and upper throat area; scratchy, slightly itchy sensation at the back of my mouth and upper throat area; scratchy, slightly itchy sensation at the back of my mouth and upper throat area; mild tiredness; soreness in the injection area; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 08Apr2021 14:15 (Lot number: ER8729) at the age of 61 years as dose 1, single and administered in arm right, administration date 29Apr2021 14:15 (Lot number: ER8736) (at the age of 61-year-old) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Allergy to metals/ Nickel Sensitivity" (unspecified if ongoing); "Allergy to molds/ Mold/Mildew" (unspecified if ongoing). There were no concomitant medications. Past drug history included: BACTRIM, reaction: "Drug allergy". The following information was reported: ORAL PRURITUS (non-serious), THROAT IRRITATION (non-serious), ORAL DISORDER (non-serious) all with onset 08Apr2021 14:45, outcome "recovered" and all described as "scratchy, slightly itchy sensation at the back of my mouth and upper throat area"; FATIGUE (non-serious) with onset 08Apr2021 14:45, outcome "recovered", described as "mild tiredness"; VACCINATION SITE PAIN (non-serious) with onset 08Apr2021 14:45, outcome "recovered", described as "soreness in the injection area". Therapeutic measures were not taken as a result of oral pruritus, throat irritation, oral disorder, fatigue, vaccination site pain.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. It was reported approximately 20-30 minutes after each dose, the patient experienced a scratchy, slightly itchy sensation at the back of mouth and upper throat area.  The patient did not report this symptom at her second vaccine visit- forgot about it actually. After receiving her second dose she knew for sure that it was related, though after her first dose she had strong conclusion. She would equate the feeling as "like coming down with something." In both cases, the feeling was mild and lasted five to six hours. Of note, she was a Respiratory Therapist, but not currently practicing- she had been unemployed since a few months before COVID-19. Other than that she only experienced mild tiredness and soreness in the injection area that went away within a couple days. Event onset date was reported as 08Apr2021 at 14:45. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Delayed rash at injection site. Arm is red, warm, painful, sore and itching. Skin appears red, shiny and indurated (hard).  Rash started approx 6 days after vaccine. No fevers or other symptoms.
Body ache, headache, fever, swollen arm pits, swollen tongue, sores on tongue & mouth.
Patient complains of a migraine that has persisted for a few days. Is unsure if related but asked for the migraine to be reported as a possible side effect.
2 weeks after the vaccine the patient began getting hives & itching on inner wrist.  She used benadryl & hydrocortisone which she said helped temporarily.  She was advised to see a doctor for the rash &  regarding her 2nd dose.
4Mar91 pt "cranky" & had 1 episode vomiting. Diarrhea started. 6Mar91 rash began to appear.T 101.6 axillary. 7Mar91 saw MD. 9Mar-11Mar91 rash @ peak fullness.Diarrhea conts, No further documented T, no lymphadenopathy
Patient received pneumonia vaccine. Patient called next day c/o very painful RD. Stated he couldn't move his arm was offered appointment to come in he declined - was told to report to clinic 10-3*07 if worse. Called to check on patient 10-3-07 no answer.
Information has been received from a registered nurse concerning a 9 month old patient who on 26-APR-2011 and 27-JUN-2011 was vaccinated orally with the first dose and the second dose of 2ml ROTATEQ (Lot# not reported) respectively. On 15-NOV-2011, the patient received the third dose of 2ml ROTATEQ (Lot# not reported) orally, late. The nurse reported that the patient was 9 months old instead of 8 months old when the patient received the third dose of ROTATEQ. No adverse effects were reported. It was unknown if the patient sought medical attention. Additional information has been requested.
Patient received a dose of FluAd on 9/5/20, Patient already received flu vaccine of Fluzone HD on 8/25/20. Patient stated that she had extreme diarrhea and dehydration for several days after the second vaccination. Patient came in for a Shingles vaccine instead the patient received another HD flu vaccine.
POTENTIAL ADVERSE EVENT (AE); This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced possible adverse event (ae). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of possible adverse event (ae) was not reported. This report was non-serious.
Within 5 min my pulse was racing 120 plus and I did not feel right.  I turned very red, my BP went way up like 225/120. EMT hooked me up to a monitor and kept me there for approx 30 min. My BP and pulse started to come down and they let me go home.  Very tired rest of day and lightheaded.  Slept for 12 hours that night.  Next day felt better.
A non-serious spontaneous report of administration to 57-year-old was received from a health professional concerning a 57-year-old male. Neither relevant past medical history nor concomitant medications were reported for this patient. The patient received FLUIMST on 27-Sep-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Reaction to Polio & Tetanus right shoulder swollen & red with heat. Swollen under arm. Given antibiotics & quarters for 72 hours on 22 Apr 04.
approx 5min post vax pt devel hives 2-3 on rt upper thigh; the area then became edematous & reddened; seen by MD given DPH & ice applied pt observed x 1 hr;
Approximately 24 hrs after 1st Pfizer Covid-19 vaccine injection- itchy burning rash on inner right wrist and arm. Subsequently moving to inner left wrist and arm, stomach, back, under breasts, vagina, bottom of feet
Swelling and redness at injection site. Fatigue. Headache. Chills. Body aches.
Information has been received from a physician's assistant concerning a 22 year old female with a history of an unspecified reaction to Lortab who on 14-MAR-2007 was vaccinated with her second dose of Gardasil (lot# 657617/0384U). Concomitant therapy included unspecified birth control. The patient experienced pain at the injection site. As of 31-MAY-2007 she was recovering. Additional information has been requested.
LITTLE TO NO SIDE EFFECTS; This spontaneous report received from a patient via a company representative concerned a 60 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced little to no side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of little to no side effects was not reported. This report was non-serious. This case, from the same reporter is linked to 20220362145.
I experienced the following side effects on 02/27/2021:  extreme fatigue aches and pains in my joints sore arm at the injection site low grade fever ( I felt warm ) sweating profusely slept a lot bowels were a bit looser than usual  I stayed home from work one day.
Initial report received from healthcare professional on 19 September 2012. An 81-years old female patient, whose illness at the time of vaccination was none and medical history was reported as allergy to penicillin and had a history of elevated blood pressure and whose concomitant medications were not reported, received a dose of ADACEL vaccine, lot number C4023AA (route and site of administration were not reported) on 13 September 2012. It was reported that on 18 September 2012, the patient experienced development of hard knot at injection site with 1 and a half inch area of redness which was hot to touch around injection site with slight soreness. The corrective treatments and laboratory investigations were not reported. At the time of this report, the patient had not recovered. Documents held by sender: None. Follow-up information received on 19 November 2012: The patient had received ADACEL vaccine intramuscularly on the right deltoid. The soreness at the injection was no more reported in follow-up information. On 18 September 2012, the patient developed a 1.5-inch diameter red area with heat, swelling and itching at injection site. The severity of the reaction was reported as moderate. The patient was treated with TYLENOL by mouth and BENADRYL cream topical to help with side effects and was instructed to let her doctor know if situation worsens.
Pt's left thigh developed slight ecchymosis and induration about quarter-sized with no erythema or cellulitis. Pt is recovering.
w/in 24hr of vax pt devel a fever of 103, nausea, body aches, chills, muscle spasms & an inj site rxn characterized by redness, warmth & swelling;
Fever, body aches, nausea, headache, lethargy, swelling, heat & redness at site of immunization.
Patient reported getting home after the vaccine and feeling not well.  She reports flu like symptoms, feels body aches, and fatigue for the last week since vaccination.  I advised the patient that since it would take approximately 2 week to have full immunity after the vaccine, she may have been exposed to the flu virus or another illness before and/or after the vaccine.  I suggested she contact her doctor and if she could not get an appointment right away, to seek care at a walk in or urgent care facility.
Pt had swallening. Redness on whole left arm & painful also. Started 2nd day after vaccine. Dr inject steroid and pt was ok after.
Patient came in today 4/14/2021 report that she had an adverse reaction to her first covid vaccine.  It began on 03/21/2021, which is 4 days following her receiving her vaccine.  She stated that she developed a rash on her back, stomach and upper arms on the 21st of March.  Patient stated on 03/25/2021 she went to the Dermatologist who instructed her to take and prescribed her Prednisone and Benadryl and diagnosed her with contact dermatitis.   On 04/09/2021 she developed severe head and neck pain and went to the ER.  When she arrived  at the ER her blood pressure was 150/100 and got as high as 195/150 per patient report.  She stated they did an EKG per her request and gave her propanol. Per patient  her Blood Pressure was still 150/100 when she was discharged from the ER.
Information has been received from a license practical nurse concerning a 12 month old male who was vaccinated SQ with 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live.  Subsequently the patient experienced rash.  The patients' outcome was not reported. Additional information has been requested.
My right arm has a huge red swollen circle about 5 inches below the injection site.   This area didn?t appear until day 9.   I also am having extreme fatigue at day 11.
Fever of 100.5 for a day, but continuing, sporadic extra fatigue and inflammation of mouth.
I was told the she had a raised red oval shaped area around injection site, about the size of 2 fifty cent coins. The area was sore and hot to the touch. It also hurt when she moved her arm. That was 6 days post injection. They put ice on the site and were advised to take benadryl. It is unknown if she took the benadryl. Two days later I called to check on patient and was told the area was much less red and less sore. The area was no longer raised or hot to the touch.
arm discomfort; limited range of motion of arm; This case was reported by a pharmacist via call center representative and described the occurrence of arm discomfort in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number JC55P, expiry date 15th November 2021) for prophylaxis.   On 15th August 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 16th August 2019, 1 days after receiving Shingrix, the patient experienced arm discomfort and joint range of motion decreased. On an unknown date, the outcome of the arm discomfort and joint range of motion decreased were recovering/resolving.   It was unknown if the reporter considered the arm discomfort and joint range of motion decreased to be related to Shingrix.  Additional details were provided as follows: The reporter stated that the patient experienced arm discomfort and limited range of motion of his arm. The reporter stated that the events had slightly improved but has not resolved at the time of reporting. The reporter consented to follow up. This case is 1 of the 2 linked cases, reported by the same reporter.
Pt received Pfizer first dose @ 1420 @1425 pt reported itching to neck, denies SOB or chest pain; vitals WNL @1427 Benadryl 25mg IM admin per MD order; pt tolerated well. @1429 vitals WNL; denies SOB or chest pain @1445 vitals WNL, pt denies SOB or chest pain; pt reports no longer itching @ 1457 vitals WNL; pt waiting for ride; denies SOB or chest pain @1557 pt reports itching again; Dexamethasone 4mg tab PO admin per Dr order; pt tolerated well. @1630 vitals WNL, denies SOB or chest pain, pt reports relief from itching; son picked up pt to go home. Pt left with steady gait/ with walker and no signs of distress.